Stay updated on Tresiba Long-term Use Post-marketing Clinical Trial
Sign up to get notified when there's something new on the Tresiba Long-term Use Post-marketing Clinical Trial page.

Latest updates to the Tresiba Long-term Use Post-marketing Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. This is a minor site/template update and does not affect the study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page shows a new footer revision tag 'Revision: v3.3.3' and removal of the 'HHS Vulnerability Disclosure' link, along with the preceding 'Revision: v3.3.2' tag. These are surface-level maintenance updates not affecting core content or user-facing functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.1%

- Check64 days agoChange DetectedThe government funding/operating-status notice at the top of the page was removed; this means the page no longer warns that updates may be delayed, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check79 days agoChange DetectedPage layout and header spacing were refreshed; all sections (Overview, Eligibility Criteria, Study Plan, Contacts) remain present and unchanged in content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check107 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference6%

Stay in the know with updates to Tresiba Long-term Use Post-marketing Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tresiba Long-term Use Post-marketing Clinical Trial page.